OTOTOXICITY OF CHEMOTHERAPEUTIC-AGENTS

被引：0
作者：
SCHWEITZER, VG [1 ]
机构：
[1] UNIV MICHIGAN, MED CTR, ANN ARBOR, MI 48109 USA
来源：
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 1993年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：759 / 789
页数：31
相关论文
共 50 条
[41]   CHEMOTHERAPEUTIC-AGENTS CAUSE MALIGNANT TRANSFORMATION [J].
JONES, PA ;
BENEDICT, WF .
CLINICAL RESEARCH, 1975, 23 (02) :A163-A163
[42]   ANTIBODIES AS SPECIFIC CARRIERS FOR CHEMOTHERAPEUTIC-AGENTS [J].
LEE, FH ;
HWANG, KM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 3 (01) :17-24
[43]   GENERAL MEDICAL PRESCRIPTIONS OF CHEMOTHERAPEUTIC-AGENTS [J].
SZIEGOLEIT, W ;
MOUCHAIREFA, C .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) :470-471
[44]   THE USES OF SYSTEMIC CHEMOTHERAPEUTIC-AGENTS IN PSORIASIS [J].
MCDONALD, CJ .
PHARMACOLOGY & THERAPEUTICS, 1981, 14 (01) :1-24
[45]   INFLUENCE OF CHEMOTHERAPEUTIC-AGENTS ON MONOCYTE FUNCTION [J].
MELO, JC ;
DYSON, SA .
CLINICAL RESEARCH, 1982, 30 (02) :A374-A374
[46]   HYPERSENSITIVITY REACTIONS TO CANCER CHEMOTHERAPEUTIC-AGENTS [J].
WEISS, RB ;
BRUNO, S .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (01) :66-72
[47]   ADMINISTRATION OF CHEMOTHERAPEUTIC-AGENTS - TECHNIQUES AND CONTROVERSIES [J].
RAAF, JH .
SUPPORTIVE CARE IN CANCER, 1994, 2 (06) :335-346
[48]   DESIGN OF EXPERIMENTAL CANCER CHEMOTHERAPEUTIC-AGENTS [J].
CAIN, BF .
NEW ZEALAND MEDICAL JOURNAL, 1977, 86 (595) :247-247
[49]   THE RENAL TOXICITY OF CANCER CHEMOTHERAPEUTIC-AGENTS [J].
WEISS, RB ;
POSTER, DS .
CANCER TREATMENT REVIEWS, 1982, 9 (01) :37-56
[50]   DIACRIDINES - DOUBLE INTERCALATORS AS CHEMOTHERAPEUTIC-AGENTS [J].
CANELLAKIS, ES ;
FICO, RM ;
SARRIS, AH ;
SHAW, YH .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (02) :231-236
12345